Lataa...
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy
BACKGROUND: Azilsartan (AZI) is a relatively new angiotensin receptor blocker available for the treatment of any stage of hypertension, which was eventually given in combination with chlorthalidone (CLT). OBJECTIVE: To review pharmacology and clinical role of AZI monotherapy and AZI/CLT or AZI/amlod...
Tallennettuna:
| Julkaisussa: | Core Evid |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4829189/ https://ncbi.nlm.nih.gov/pubmed/27103882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S81776 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|